Signs of the CBS-MP (26.5% and 38.5%, respectively) were slightly more frequent than signs of the PSP-MP (20.4% and 30.8%, respectively) in GRN and MAPT pathogenic variant carriers. The gene discussed is CBS; the disease is supranuclear palsy, progressive, 1.